Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25.5K Buy
+19,780
New +$32.7K 0.01% 453
2025
Q4
Sell
-14,683
Closed -$23.8K 636
2025
Q3
$23.8K Sell
14,683
-1,328
-8% -$2.78K 0.01% 524
2025
Q2
$41.5K Buy
+16,011
New +$63.2K 0.02% 404
2025
Q1
Sell
-6,763
Closed -$45.9K 964
2024
Q4
$45.9K Buy
+6,763
New +$44.5K 0.04% 526

Other funds holding LUNG

R Squared's LUNG Position: Q1 2026 in Review

R Squared opened a new position in Pulmonx (LUNG) in Q1 2026: 19,780 shares worth $25.5K. The stake represents 0.01% of the portfolio and ranks #453 among its holdings. This is a return to the name: R Squared previously reported a position in LUNG as recently as Q3 2025.

R Squared first reported a position in LUNG in Q4 2024 and has held it in 4 quarters since. The position peaked at $45.9K in Q4 2024. 113 funds tracked by Wall St. Rank hold LUNG as of Q1 2026.

  • R Squared held 19,780 shares of Pulmonx worth $25.5K as of Q1 2026.
  • Pulmonx was a new R Squared position in Q1 2026.
  • Pulmonx made up 0.01% of R Squared's portfolio in Q1 2026, its #453 holding.
  • R Squared first reported a position in Pulmonx in Q4 2024 and has held it in 4 quarters since.
  • R Squared's Pulmonx position peaked at $45.9K in Q4 2024.
  • 113 funds tracked by Wall St. Rank held Pulmonx as of Q1 2026.

Based on R Squared's 13F filing for Q1 2026, filed 29 Apr 2026.